Bibliografía
-Referencias Bibliográficas-
1) Eichhorn JH. Md.:Medullary carcinoma, provocative now as then Semen Diagn Pathol. 2004 Feb; 21 (1):65-73
2) Pedersen L, Zedeler K, Holck S et al.:Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in brest cancer. Eur J. Cancer 1995 Dec; 31(A) (13-14): 2289-95
3) Contesso G, Rapin-Marion V, Mouriesse H.:Medulary carcinoma of the breast.Whats remains of this entity today?. Arch Anat Cytol Pathol. 1995; 43 (1-2):44- 50
4) Gaffey MJ, Mills SE, Frierson HF et al.: Medullary carcinoma of the breast interobserver variability in histopatologic diagnosis Med. Pathol. 1995 Jan; 8 (1): 31-8
5) Tisserand P, Fouguet C,Barrois M et al.: Lack of HIN-1 methylation dfines specific breast tumor subtypes including medullary carcinoma of the breast and BRCA-1 liked tumor Cancer Biol Ther. 2003 Sep-Oct; 2 (5): 564-5
6) Cook DL, Wearver Dl.: Comparison of DNA content, S- phase fraction, and survival between medullary and ductal carcinoma of de breast. Am. J. Clin Pathol. 1995 Jul; 104 (1) :17-22
7) Tamiolakis D, Simopoulos C, Cheva A.: Immunophenotypic profile of tumor infiltrating lymphocites in medullary carcinoma of the breast. Eur J Gynaecol Oncol. 2002; 23 (5):433-6
8) Jensen ML, Andersen J et al .: Prognostic comparison of three classifications for medullary carcinomas of the breast. Histophatology. 1997 Jun; 30 (6): 523-32
9) Eisinger F, Jacquemier J, Charpin C et al .: Mutations at BRCA-1 the medullary breast carcinoma revisited. Cancer Res. 1998 Apr 15; 58 (8): 1588-92.
10) Dendale R, Vincent-Salomon A, Mouret-Foume E et al : Medullary breast carcinoma: prognostic implications of p53expression. Int J. Biol Markers. 2003 Apr-Jun; 18 (2) :99-105
11) González Ortega JM, López Cuevas ZC.: Formas especiales del cáncer mamario. La enfermedad de Pager y el Cáncer medular. Trabajo presentado en la Jornada Provincial de Cirugía Matanzas 2003. Centro de Convenciones Plaza América Varadero, 17 mayo 2003
12) Xu R, Feinter H, Li P et al .:Differential amplification and overexpression of HER-2/neu, p53, M1B1, and estrogen receptor/proge3sterone receptor among medullary carcinoma atypical medullary carcinoma, and high grade invasive ductal carcinoma of the breast. Arch Pathol Lab Med. 2003 nov;127 (11):1458-64
13) Kleer CG , Michael CW. Fine-needle aspiration of breast carcinomas with prominent linphocytic infiltrate. Diag Cytopatthol. 2000 Jul; 23 (1): 39-42
14) Sainz Ballesteros J, Ancheta Niebla O.: Ultraestructura de los fibroblastos en lesiones de la mama, tumorales y no tumorales. Tesis para la obtención del grado Científico de Candidato a Doctor en Ciencias Médicas. Centro Nacional de Investigaciones Cientificas. Ciudad Habana, 1987
15) Cheng YC, Lebe B, Balci P et al.: Sonographic and pathologic findings in typical and atypical medullary carcinoma of the breast. J. Clin Ultrasound. 2000 Sep; 28 (7): 325-31
16) Yilmar E, Lebe B, Balci P et al.: Comparison of mamographic and sonographic findings in typical and atypical medullary carcinoma of the breast. Cli Radiol. 2002 Jul ; 57 (7): 640-5
17) Reinfuss M, Stelmach A, Mitus J et al.: Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J. Surg Oncol. 1995 Oct; 60 (2) :89-94
18) Mitre M, Goupel E.: Prognostic factors in medullary breast cancer. Gebrutshilfe Frannenheillyl. 2000 Jul; 49(7): 635-41.
|